Chlorpheniramine Maleate

Manufacturer: Cardinal Health, Inc. | KVK-Tech, Inc.
Effective date: 2012-08-30
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: legacy-cache
Hydrated at: 2026-08-02 01:45:15

Label at a glance#

ProductChlorpheniramine Maleate

Active ingredientCHLORPHENIRAMINE MALEATE

Label structure9 sections

Indications and uses

temporarily relieves the following symptoms due to hay fever or other upper respiratory allergies: sneezing runny nose itchy, watery eyes itching of the nose or throat

Dosage and administration

adults and children 12 years and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours. children under 12 years of age: ask a doctor

Storage and handling

each tablet contains: calcium 28 mg store between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F) protect from excessive moisture

Contacts and useful links#

PhoneFDA MedWatch1-800-FDA-1088

Label contents#

Full prescribing information#

Chlorpheniramine maleate 12 mg

OTC - ACTIVE INGREDIENT SECTION

Antihistamine

USES

INDICATIONS & USAGE SECTION

temporarily relieves the following symptoms due to hay fever or other upper respiratory allergies:
sneezing
runny nose
itchy, watery eyes
itching of the nose or throat

WARNINGS

WARNINGS SECTION

Ask a doctor before use if you have
a breathing problem such as emphysema or chronic bronchitis
glaucoma
trouble urinating due to an enlarged prostate gland
Ask a doctor or pharmacist before use if you are
taking sedatives or tranquilizers
When using this product
excitability may occur, especially in children
drowsiness may occur
avoid alcoholic beverages
alchohol, sedatives and tranquilizers may increase drowsiness
use caution when driving a motor vehicle or operating machinery
Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088
If pregnant or breast-feeding, ask a health professional before use

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours.
children under 12 years of age: ask a doctor

OTHER INFORMATION

STORAGE AND HANDLING SECTION

each tablet contains: calcium 28 mg
store between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F)
protect from excessive moisture

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

calcium sulfate, carnauba wax, colloidal silicon dioxide, confectioner’s sugar, D&C yellow No. 10 aluminum lake, FD&C blue No. 2/indigo carmine aluminum lake, FD&C yellow No. 6, gelatin, hydroxypropyl methylcellulose, lactose monohydrate, magnesium stearate, methacrylic acid copolymer, methyl parahydroxybenzoate, microcrystalline cellulose, pharmaceutical ink, polysorbate 80, povidone, propyl parahydroxybenzoate, propylene glycol, sodium benzoate, sodium lauryl sulphate, sucrose, talc, titanium dioxide, triethyl citrate

PURPOSE

OTC - PURPOSE SECTION

Chlorpheniramine maleate 12 mg is used as an antihistamine.

Manufactured by:
KVK-Tech, Inc.
Newtown, PA 18940
f2f01039-figure-01

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 37205-117-62
Allergy Tablets

Chlorpheniramine maleate 12 mg

f2f01039-figure-02

RxCUI, Display, Full name table
RxCUI	Display	Full name	Type	Form / route
1363288	Chlorpheniramine XR (Oral Pill)	12 HR chlorpheniramine maleate 12 MG Extended Release Oral Tablet	SCD Active

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
37205-117-62	2025-04-04	C162847	48780-1	9d75b9d0-0397-f424-e053-dadaa90a57ce	Unknown Title
37205-117-62	2020-01-31	C162847	48780-1	9d75b9d0-0397-f424-e053-dadaa90a57ce	Unknown Title

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
37205-117-62	EA - Each	37205-117	c2c57ce1-8d4d-4f27-b2d1-66e835efdd8d	1	2014-07-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CHLORPHENIRAMINE MALEATE	ACTIVE INGREDIENT	V1Q0O9OJ9Z	1
CHLORPHENIRAMINE	ACTIVE MOIETY	3U6IO1965U	1
CALCIUM SULFATE	INACTIVE INGREDIENT	WAT0DDB505	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	1
SODIUM LAURETH SULFATE	INACTIVE INGREDIENT	BPV390UAP0	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	1
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

Chlorpheniramine Maleate
CHLORPHENIRAMINE
CALCIUM SULFATE
CARNAUBA WAX
SILICON DIOXIDE
SUCROSE
D&C YELLOW NO. 10
FD&C BLUE NO. 2
GELATIN
HYDROXYPROPYL CELLULOSE
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
METHYLPARABEN
CELLULOSE, MICROCRYSTALLINE
POLYSORBATE 80
POVIDONE
PROPYLENE GLYCOL
SODIUM BENZOATE
SODIUM LAURETH SULFATE
TITANIUM DIOXIDE
TRIETHYL CITRATE
FD&C YELLOW NO. 6
TALC

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
37205-117	37205-117-62

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CHLORPHENIRAMINE MALEATE	V1Q0O9OJ9Z	ACTIB
CALCIUM SULFATE	WAT0DDB505	IACT
CARNAUBA WAX	R12CBM0EIZ	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SUCROSE	C151H8M554	IACT
D&C YELLOW NO. 10	35SW5USQ3G	IACT
FD&C BLUE NO. 2	L06K8R7DQK	IACT
GELATIN	2G86QN327L	IACT
HYDROXYPROPYL CELLULOSE	RFW2ET671P	IACT
LACTOSE MONOHYDRATE	EWQ57Q8I5X	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	NX76LV5T8J	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT
POVIDONE	FZ989GH94E	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
SODIUM LAURETH SULFATE	BPV390UAP0	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
TRIETHYL CITRATE	8Z96QXD6UM	IACT
FD&C YELLOW NO. 6	H77VEI93A8	IACT
TALC	7SEV7J4R1U	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 14 · 781 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
GELATIN	GELATIN	2G86QN327L	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	14 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	CAPSULE, DELAYED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	POWDER / ORAL		50 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	53 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	INSERT / VAGINAL		8 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	690 mg		Exact identifier — unii candidate 38 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CREAM / VAGINAL		22 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	OINTMENT / DENTAL	NA		Exact identifier — unii candidate 81 equally ranked IID candidates
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, COATED / ORAL		1301 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
TRIETHYL CITRATE	TRIETHYL CITRATE	8Z96QXD6UM	CAPSULE, DELAYED RELEASE / ORAL		70 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
FD&C BLUE NO. 2	FD&C BLUE NO. 2	L06K8R7DQK	CAPSULE / ORAL		4 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SPRAY / NASAL	0.01 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE / ORAL		254 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	GUM, CHEWING / BUCCAL		24 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
SODIUM LAURETH SULFATE	SODIUM LAURETH-3 SULFATE	BPV390UAP0	SPRAY / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 5 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / RECTAL	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / RESPIRATORY (INHALATION)	0.13 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
TRIETHYL CITRATE	TRIETHYL CITRATE	8Z96QXD6UM	SUSPENSION / ORAL		71 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	AEROSOL, FOAM / VAGINAL	6.4 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	750 mg		Exact identifier — unii candidate 38 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SPRAY / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	GRANULE, FOR SUSPENSION / ORAL		278 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 44 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, DELAYED RELEASE / ORAL		66 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
CARNAUBA WAX	CARNAUBA WAX	R12CBM0EIZ	TABLET, EXTENDED RELEASE / ORAL		2150 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	CAPSULE, LIQUID FILLED / ORAL		1042 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	GUM, CHEWING / ORAL		2 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	AEROSOL, METERED / RECTAL	NA		Exact identifier — unii candidate 81 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET / ORAL		2734 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION / SUBCUTANEOUS		98 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	EMULSION / OPHTHALMIC	1.5 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SOLUTION / OPHTHALMIC		8 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR		2 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION / SUBCUTANEOUS	16 %w/v		Exact identifier — unii candidate 44 equally ranked IID candidates
TRIETHYL CITRATE	TRIETHYL CITRATE	8Z96QXD6UM	INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR		10 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	SUSPENSION / ORAL	20 mg/5ml		Exact identifier — unii candidate 31 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SUSPENSION / ORAL		2553 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CARNAUBA WAX	CARNAUBA WAX	R12CBM0EIZ	TABLET / ORAL	167.8 mg		Exact identifier — unii candidate 11 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		357 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	SOLUTION / ORAL		8 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	POWDER, FOR SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CONCENTRATE / ORAL		12 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SYSTEM / TOPICAL		42 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	17 mg		Exact identifier — unii candidate 30 equally ranked IID candidates
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	NX76LV5T8J	CAPSULE, EXTENDED RELEASE / ORAL		283 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
FD&C BLUE NO. 2	FD&C BLUE NO. 2	L06K8R7DQK	TABLET, DELAYED RELEASE / ORAL	0.2 mg		Exact identifier — unii candidate 11 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GRANULE, DELAYED RELEASE / ORAL		525 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRADERMAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040829-001	CHLORPHENIRAMINE MALEATE	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL		RS	2009-05-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040829-001	CHLORPHENIRAMINE MALEATE	12MG	TABLET, EXTENDED RELEASE / ORAL	RS	2009-05-13	`3a93d1ddd44b…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
1e3ecf30-e5e7-49b2-a35b-7a66c0e2b55b			cade2f27-fc17-4538-bcdc-67bafd85371d	2025-04-03	Warnings	Exact identifier spl set id: cade2f27-fc17-4538-bcdc-67bafd85371d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Chlorpheniramine Maleate

Label at a glance#

Indications and uses

Dosage and administration

Storage and handling

Contacts and useful links#

Label contents#

Full prescribing information#

Chlorpheniramine maleate 12 mg

USES

WARNINGS

KEEP OUT OF REACH OF CHILDREN

DIRECTIONS

OTHER INFORMATION

INACTIVE INGREDIENTS

PURPOSE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Related RxNorm Concepts#

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

DailyMed Socrata Ingredients#

Products#

NDC Codes#

Ingredients#

Source Document#

Inactive ingredient matches#

Orange Book application contexts#

Orange Book products#

Observed Orange Book product history#

openFDA label cross-check#

Reported adverse events (FAERS/openFDA)#